UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Amblyopia in children: Management and outcome

Authors
David K Coats, MD
Evelyn A Paysse, MD
Section Editor
Richard A Saunders, MD
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

Amblyopia is a functional reduction in visual acuity caused by abnormal visual development early in life. It is the most common cause of pediatric visual impairment, occurring in 1 to 4 percent of children. Early detection and treatment of amblyopia improves visual outcomes. This is the basis for screening preschool-age children for vision problems and amblyopia (table 1A-B). (See "Screening tests in children and adolescents", section on 'Vision screen'.)

The management and outcome of amblyopia in children is reviewed here. The definition, classification, and diagnosis of amblyopia are reviewed separately. (See "Amblyopia in children: Classification, screening, and evaluation".)

The management of strabismus and refractive errors in children are also discussed separately. (See "Evaluation and management of strabismus in children" and "Refractive errors in children".)

TERMINOLOGY

Amblyopia is classified by the underlying cause of the visual disturbance [1]:

Strabismic amblyopia — Caused by abnormal alignment of the eyes (see "Amblyopia in children: Classification, screening, and evaluation", section on 'Strabismic amblyopia' and "Evaluation and management of strabismus in children")

                    

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Tue Mar 29 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Day S. Normal and abnormal visual development. In: Pediatric Ophthalmology, Taylor D (Ed), Blackwell Scientific Publications, Cambridge, MA 1990. p.7.
  2. American Academy of Ophtalmology Pediatric Ophthalmology/Strabismus Panel. Preferred Practice Pattern Guidelines. Amblyopia. American Academy of Ophthalmology, San Francisco, CA: American Academy of Ophthalmology; 2012. Available at: http://www.aao.org/preferred-practice-pattern/amblyopia-ppp--september-2012 (Accessed on August 05, 2015).
  3. Repka MX, Kraker RT, Holmes JM, et al. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial. JAMA Ophthalmol 2014; 132:799.
  4. Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993; 100:323.
  5. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol 1999; 83:582.
  6. Repka MX, Wallace DK, Beck RW, et al. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005; 123:149.
  7. Holmes JM, Lazar EL, Melia BM, et al. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol 2011; 129:1451.
  8. Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998; 96:431.
  9. Assaf AA. The sensitive period: transfer of fixation after occlusion for strabismic amblyopia. Br J Ophthalmol 1982; 66:64.
  10. Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005; 123:437.
  11. Cotter SA, Pediatric Eye Disease Investigator Group, Edwards AR, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 2006; 113:895.
  12. Stewart CE, Moseley MJ, Fielder AR, et al. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2004; 88:1552.
  13. Writing Committee for the Pediatric Eye Disease Investigator Group, Cotter SA, Foster NC, et al. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology 2012; 119:150.
  14. Taylor K, Powell C, Hatt SR, Stewart C. Interventions for unilateral and bilateral refractive amblyopia. Cochrane Database Syst Rev 2012; :CD005137.
  15. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified? Br J Ophthalmol 2000; 84:572.
  16. Mazow ML, Chuang A, Vital MC, Prager T. 1999 Costenbader Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 2000; 4:1.
  17. France TD, France LW. Optical penalization can improve vision after occlusion treatment. J AAPOS 1999; 3:341.
  18. Simons K, Gotzler KC, Vitale S. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997; 104:2156.
  19. Taylor K, Elliott S. Interventions for strabismic amblyopia. Cochrane Database Syst Rev 2014; :CD006461.
  20. Holmes JM, Edwards AR, Beck RW, et al. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 2005; 9:129.
  21. Pediatric Eye Disease Investigator Group, Wallace DK, Lazar EL, et al. A randomized trial of increasing patching for amblyopia. Ophthalmology 2013; 120:2270.
  22. Wallace DK, Lazar EL, Crouch ER 3rd, et al. Time course and predictors of amblyopia improvement with 2 hours of daily patching. JAMA Ophthalmol 2015; 133:606.
  23. Wallace DK, Pediatric Eye Disease Investigator Group, Edwards AR, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 2006; 113:904.
  24. Beardsell R, Clarke S, Hill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophthalmol Strabismus 1999; 36:19.
  25. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc 1999; 97:373.
  26. Holmes JM, Kraker RT, Beck RW, et al. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 110:2075.
  27. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003; 136:620.
  28. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121:603.
  29. Stewart CE, Stephens DA, Fielder AR, et al. Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ 2007; 335:707.
  30. Lithander J, Sjöstrand J. Anisometropic and strabismic amblyopia in the age group 2 years and above: a prospective study of the results of treatment. Br J Ophthalmol 1991; 75:111.
  31. Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986; 102:340.
  32. Newsham D. A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy. Br J Ophthalmol 2002; 86:787.
  33. Tjiam AM, Holtslag G, Vukovic E, et al. An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants. Ophthalmology 2012; 119:2393.
  34. Dean SE, Povey RC, Reeves J. Assessing interventions to increase compliance to patching treatment in children with amblyopia: a systematic review and meta-analysis. Br J Ophthalmol 2016; 100:159.
  35. Dorey SE, Adams GG, Lee JP, Sloper JJ. Intensive occlusion therapy for amblyopia. Br J Ophthalmol 2001; 85:310.
  36. Arnold RW, Armitage MD, Limstrom SA. Sutured protective occluder for severe amblyopia. Arch Ophthalmol 2008; 126:891.
  37. Rubab S, French D, Levin AV. Glued patches for children resistant to amblyopia occlusion therapy. Arch Ophthalmol 2008; 126:133.
  38. Repka MX. How much amblyopia treatment is enough? Arch Ophthalmol 2008; 126:990.
  39. Simon JW, Parks MM, Price EC. Severe visual loss resulting from occlusion therapy for amblyopia. J Pediatr Ophthalmol Strabismus 1987; 24:244.
  40. Pediatric Eye Disease Investigator Group.. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002; 120:268.
  41. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol 1997; 81:54.
  42. Scheiman MM, Hertle RW, Kraker RT, et al. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol 2008; 126:1634.
  43. Li T, Shotton K. Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Database Syst Rev 2009; :CD006460.
  44. Pediatric Eye Disease Investigator Group, Repka MX, Kraker RT, et al. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol 2008; 126:1039.
  45. Repka MX, Cotter SA, Beck RW, et al. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004; 111:2076.
  46. Holmes JM, Strauber S, Quinn GE, et al. Further validation of the Amblyopia Treatment Index parental questionnaire. J AAPOS 2008; 12:581.
  47. Felius J, Chandler DL, Holmes JM, et al. Evaluating the burden of amblyopia treatment from the parent and child's perspective. J AAPOS 2010; 14:389.
  48. Hunter DG. Treatment of amblyopia in older children. Arch Ophthalmol 2005; 123:557.
  49. Walsh LA, Hahn EK, Laroche GR. Stability of visual acuity after the cessation of amblyopia treatment: review of the literature. Am Orthopt J 2007; 57:89.
  50. Pediatric Eye Disease Investigator Group, Wallace DK, Lazar EL, et al. A randomized trial of adding a plano lens to atropine for amblyopia. J AAPOS 2015; 19:42.
  51. De Weger C, Van Den Brom HJ, Lindeboom R. Termination of amblyopia treatment: when to stop follow-up visits and risk factors for recurrence. J Pediatr Ophthalmol Strabismus 2010; 47:338.
  52. Holmes JM, Melia M, Bradfield YS, et al. Factors associated with recurrence of amblyopia on cessation of patching. Ophthalmology 2007; 114:1427.
  53. Walsh LA, Hahn EK, LaRoche GR. The method of treatment cessation and recurrence rate of amblyopia. Strabismus 2009; 17:107.
  54. Paysse EA, Coats DK, Hussein MA, et al. Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children. Ophthalmology 2006; 113:169.
  55. Tychsen L, Hoekel J. Refractive surgery for high bilateral myopia in children with neurobehavioral disorders: 2. Laser-assisted subepithelial keratectomy (LASEK). J AAPOS 2006; 10:364.
  56. Yin ZQ, Wang H, Yu T, et al. Facilitation of amblyopia management by laser in situ keratomileusis in high anisometropic hyperopic and myopic children. J AAPOS 2007; 11:571.
  57. Astle WF, Rahmat J, Ingram AD, Huang PT. Laser-assisted subepithelial keratectomy for anisometropic amblyopia in children: outcomes at 1 year. J Cataract Refract Surg 2007; 33:2028.
  58. Solebo AL, Cumberland PM, Rahi JS. Whole-population vision screening in children aged 4-5 years to detect amblyopia. Lancet 2015; 385:2308.
  59. Woodruff G. Amblyopia: could we do better? BMJ 1995; 310:1153.
  60. Rahi J, Logan S, Timms C, et al. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 2002; 360:597.
  61. Tejedor J, Ogallar C. Comparative efficacy of penalization methods in moderate to mild amblyopia. Am J Ophthalmol 2008; 145:562.
  62. Pediatric Eye Disease Investigator Group. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol 2009; 127:22.
  63. Brandies R, Yehuda S. The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev 2008; 32:611.
  64. Yang X, Luo D, Liao M, et al. Efficacy and tolerance of levodopa to treat amblyopia: a systematic review and meta-analysis. Eur J Ophthalmol 2012; :0.
  65. Pediatric Eye Disease Investigator Group, Repka MX, Kraker RT, et al. A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology 2015; 122:874.
  66. Campos EC, Schiavi C, Benedetti P, et al. Effect of citicoline on visual acuity in amblyopia: preliminary results. Graefes Arch Clin Exp Ophthalmol 1995; 233:307.
  67. Campos EC, Bolzani R, Schiavi C, et al. Cytidin-5'-diphosphocholine enhances the effect of part-time occlusion in amblyopia. Doc Ophthalmol 1996-1997; 93:247.
  68. Birch EE, Li SL, Jost RM, et al. Binocular iPad treatment for amblyopia in preschool children. J AAPOS 2015; 19:6.
  69. Li SL, Jost RM, Morale SE, et al. Binocular iPad treatment of amblyopia for lasting improvement of visual acuity. JAMA Ophthalmol 2015; 133:479.
  70. Li SL, Jost RM, Morale SE, et al. A binocular iPad treatment for amblyopic children. Eye (Lond) 2014; 28:1246.
  71. Study of Binocular Computer Activities for Treatment of Amblyopia (ATS18), available at https://www.clinicaltrials.gov/ct2/show/NCT02200211.
  72. Zhao J, Lam DS, Chen LJ, et al. Randomized controlled trial of patching vs acupuncture for anisometropic amblyopia in children aged 7 to 12 years. Arch Ophthalmol 2010; 128:1510.
  73. Lam DS, Zhao J, Chen LJ, et al. Adjunctive effect of acupuncture to refractive correction on anisometropic amblyopia: one-year results of a randomized crossover trial. Ophthalmology 2011; 118:1501.
  74. Repka MX. Acupuncture for anisometropic amblyopia. J AAPOS 2011; 15:3.
  75. Holmes JM, Beck RW, Kraker RT, et al. Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004; 8:420.
  76. Magramm I. Amblyopia: etiology, detection, and treatment. Pediatr Rev 1992; 13:7.
  77. Mirabella G, Hay S, Wong AM. Deficits in perception of images of real-world scenes in patients with a history of amblyopia. Arch Ophthalmol 2011; 129:176.
  78. Grant S, Melmoth DR, Morgan MJ, Finlay AL. Prehension deficits in amblyopia. Invest Ophthalmol Vis Sci 2007; 48:1139.
  79. Webber AL, Wood JM, Gole GA, Brown B. The effect of amblyopia on fine motor skills in children. Invest Ophthalmol Vis Sci 2008; 49:594.
  80. Niechwiej-Szwedo E, Goltz HC, Chandrakumar M, et al. Effects of anisometropic amblyopia on visuomotor behavior, part 2: visually guided reaching. Invest Ophthalmol Vis Sci 2011; 52:795.
  81. Packwood EA, Cruz OA, Rychwalski PJ, Keech RV. The psychosocial effects of amblyopia study. J AAPOS 1999; 3:15.
  82. Wen G, McKean-Cowdin R, Varma R, et al. General health-related quality of life in preschool children with strabismus or amblyopia. Ophthalmology 2011; 118:574.
  83. Rahi JS, Cumberland PM, Peckham CS. Does amblyopia affect educational, health, and social outcomes? Findings from 1958 British birth cohort. BMJ 2006; 332:820.